|
⚲
|
| Keyboard |
| Christopher Fuglesang | |
|---|---|
| Firm | |
| Address | 12860 El Camino Real Suite 300 San Diego, CA 92130 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Boxer Offshore Fund LP | 021-560956 | Executive Officer | 0.6 M | ||
| Shoreline Biosciences Inc | 021-420540 | Director | 140.0 M of 140.0 M |
||
| Shoreline Biosciences Inc | 021-389545 | Director | 43.0 M of 43.0 M |
||
| CIVI Biopharma Holdings Inc | 021-384757 | Director | 27.5 M of 27.5 M |
||
| Pandion Therapeutics HoldCo LLC | 021-364484 | Director | 40.0 M of 80.0 M |
||
| CIVI Biopharma Holdings Inc | 021-312966 | Director | 49.0 M of 49.0 M |
||
| Boxer Capital Management LLC | |||||
| Boxer Capital Master Fund LP | 021-545713 | Executive Officer | 60.2 M | 450.5 M | |